Targeting SphK1 as a New Strategy against Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|9|8|662-673

ISSN： 1389-4501

Source： Current Drug Targets, Vol.9, Iss.8, 2008-08, pp. : 662-673

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Ubiquitin E1 as a Novel Anti-Cancer Strategy

By  

Current Pharmaceutical Design, Vol. 19, Iss. 18, 2013-06 ,pp. : 3201-3209

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Monoamine Oxidases with Multipotent Ligands: An Emerging Strategy in the Search of New Drugs Against Neurodegenerative Diseases

By  

Current Medicinal Chemistry, Vol. 18, Iss. 30, 2011-10 ,pp. : 4568-4587

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the proteasome as a therapeutic strategy against haematological malignancies

By Orlowski Robert Z   Zeger Erik L  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 2, 2006-02 ,pp. : 117-130

Informa Healthcare

Access to resources Recommend Favorite

Targeting PDK1 in Cancer

By  

Current Medicinal Chemistry, Vol. 18, Iss. 18, 2011-06 ,pp. : 2763-2769

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting syndecans: a promising strategy for the treatment of cancer

By Choi Sojoong  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 6, 2013-09 ,pp. : 695-705

Informa Healthcare

Access to resources Recommend Favorite